PA
LJPC

Perceptive Advisors’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Perceptive Advisors’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-4,313,611
Closed -$41M – 131
2018
Q4 		$41M Hold
4,313,611
– – 1.56% 20
2018
Q3 		$86.8M Hold
4,313,611
– – 2.32% 8
2018
Q2 		$126M Hold
4,313,611
– – 3.3% 7
2018
Q1 		$128M Buy
4,313,611
+925,000
+27% +$29.8M 3.6% 6
2017
Q4 		$109M Buy
3,388,611
+1,231,600
+57% +$40.2M 3.61% 6
2017
Q3 		$75M Hold
2,157,011
– – 2.87% 7
2017
Q2 		$64.2M Buy
2,157,011
+17,737
+0.8% +$508K 3.23% 6
2017
Q1 		$63.9M Buy
2,139,274
+820,000
+62% +$20.9M 3.64% 5
2016
Q4 		$23.1M Sell
1,319,274
-4,050
-0.3% -$77.6K 1.64% 16
2016
Q3 		$31.5M Sell
1,323,324
-9,491
-0.7% -$179K 2.03% 10
2016
Q2 		$21.3M Buy
1,332,815
+633,300
+91% +$11.4M 1.48% 16
2016
Q1 		$14.6M Buy
699,515
+50,000
+8% +$892K 1.28% 18
2015
Q4 		$17.5M Sell
649,515
-5,000
-0.8% -$136K 1.3% 21
2015
Q3 		$18.2M Buy
654,515
+401,600
+159% +$12.7M 1.45% 16
2015
Q2 		$6.2M Hold
252,915
– – 0.37% 59
2015
Q1 		$4.63M Sell
252,915
-36,040
-12% -$731K 0.36% 55
2014
Q4 		$5.33M Buy
288,955
+38,955
+16% +$462K 0.45% 52
2014
Q3 		$2.4M Buy
+250,000
New +$2.49M 0.24% 67

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VMI
VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Perceptive Advisors's LJPC Position: Q1 2019 in Review

Perceptive Advisors sold out of La Jolla Pharmaceutical Company (LJPC) in Q1 2019, closing a stake of 4,313,611 shares — an estimated $41M sold.

Perceptive Advisors first reported a position in LJPC in Q3 2014 and held it in 18 quarters. The position peaked at $128M in Q1 2018. 80 funds tracked by Wall St. Rank hold LJPC as of Q1 2019.

  • Perceptive Advisors reported no remaining La Jolla Pharmaceutical Company position as of Q1 2019 after selling out during the quarter.
  • Perceptive Advisors sold 4,313,611 La Jolla Pharmaceutical Company shares in Q1 2019, an estimated $41M.
  • Perceptive Advisors first reported a position in La Jolla Pharmaceutical Company in Q3 2014 and held it in 18 quarters.
  • Perceptive Advisors's La Jolla Pharmaceutical Company position peaked at $128M in Q1 2018.
  • 80 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q1 2019.

Based on Perceptive Advisors's 13F filing for Q1 2019, filed 15 May 2019.